| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
[For whom the bell tolls].
|
Enferm Infecc Microbiol Clin
|
2007
|
1.96
|
|
2
|
The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis.
|
Eur J Pharmacol
|
2003
|
1.48
|
|
3
|
The lifestyle of Corynebacterium urealyticum derived from its complete genome sequence established by pyrosequencing.
|
J Biotechnol
|
2008
|
1.40
|
|
4
|
Correlation between virulence factors and in vitro biofilm formation by Escherichia coli strains.
|
Microb Pathog
|
2008
|
1.13
|
|
5
|
Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli (AIEC).
|
BMC Microbiol
|
2009
|
1.01
|
|
6
|
Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program.
|
Diagn Microbiol Infect Dis
|
2009
|
0.99
|
|
7
|
Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetyl-l-cysteine, amoxicillin, erythromycin, and levofloxacin.
|
Diagn Microbiol Infect Dis
|
2010
|
0.97
|
|
8
|
Local and systemic effects of hypertonic solution (NaCl 7.5%) in experimental acute pancreatitis.
|
Pancreas
|
2006
|
0.88
|
|
9
|
The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults.
|
Int J Antimicrob Agents
|
2002
|
0.85
|
|
10
|
In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
|
J Antimicrob Chemother
|
2007
|
0.84
|
|
11
|
Optimal dose of amoxicillin in treatment of otitis media caused by a penicillin-resistant pneumococcus strain in the gerbil model.
|
Antimicrob Agents Chemother
|
2002
|
0.84
|
|
12
|
Complete Genome Sequence of Corynebacterium urealyticum Strain DSM 7111, Isolated from a 9-Year-Old Patient with Alkaline-Encrusted Cystitis.
|
Genome Announc
|
2013
|
0.83
|
|
13
|
Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly beta-lactam-resistant Streptococcus pneumoniae.
|
Antimicrob Agents Chemother
|
2007
|
0.82
|
|
14
|
Hypertonic saline and reduced peroxynitrite formation in experimental pancreatitis.
|
Clinics (Sao Paulo)
|
2011
|
0.81
|
|
15
|
Adherence of Streptococcus pneumoniae to polystyrene plates, effect of serum on adhesion, and virulence in the gerbil otitis media model.
|
Microb Pathog
|
2007
|
0.81
|
|
16
|
Observation of microcolonies on Middlebrook 7H11 medium for rapid detection of Mycobacterium tuberculosis and the Mycobacterium avium complex in clinical samples.
|
Clin Microbiol Infect
|
1996
|
0.80
|
|
17
|
Comment on: Functional relationship between bacterial cell density and the efficacy of antibiotics.
|
J Antimicrob Chemother
|
2009
|
0.80
|
|
18
|
Effect of antibiotic treatment delay on therapeutic outcome of experimental acute otitis media caused by Streptococcus pneumoniae strains with different susceptibilities to amoxicillin.
|
Antimicrob Agents Chemother
|
2004
|
0.79
|
|
19
|
Adherence of Streptococcus pneumoniae to polystyrene plates and epithelial cells and the antiadhesive potential of albumin and xylitol.
|
Pediatr Res
|
2011
|
0.79
|
|
20
|
Infection caused by Ochrobactrum anthropi.
|
Clin Microbiol Infect
|
1996
|
0.79
|
|
21
|
Antimicrobial susceptibility of multidrug-resistant Streptococcus pneumoniae strains with penicillin MICs of 8 to 32 mg/L.
|
Diagn Microbiol Infect Dis
|
2009
|
0.79
|
|
22
|
Positive end-expiratory pressure and renal function influence B-type natriuretic peptide in patients with severe sepsis and septic shock.
|
Arq Bras Cardiol
|
2008
|
0.77
|
|
23
|
Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones.
|
Int J Antimicrob Agents
|
2006
|
0.76
|
|
24
|
Effect of erythromycin treatment delay on therapeutic outcome of experimental acute otitis media caused by Streptococcus pneumoniae.
|
J Antimicrob Chemother
|
2005
|
0.76
|
|
25
|
[Corynebacterium urealyticum: from the bedside to complete genome sequence].
|
Enferm Infecc Microbiol Clin
|
2009
|
0.76
|
|
26
|
Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs differ.
|
Antimicrob Agents Chemother
|
2005
|
0.75
|
|
27
|
Does acetaminophen interfere in the antibiotic treatment of acute otitis media caused by a penicillin-resistant pneumococcus strain? A gerbil model.
|
Pediatr Res
|
2003
|
0.75
|
|
28
|
Efficacy of cefminox compared with amoxicillin/clavulanic acid as a single dose for the prevention of intra-abdominal sepsis in mice intraperitoneally infected with different strains of Escherichia coli and one strain of Bacteroides fragilis.
|
Int J Antimicrob Agents
|
2006
|
0.75
|
|
29
|
In vivo activity of amoxicillin/clavulanic acid and erythromycin in experimental otitis media caused by Streptococcus pneumoniae plus Haemophilus influenzae.
|
Int J Antimicrob Agents
|
2004
|
0.75
|
|
30
|
Impact of ibuprofen therapy in the outcome of experimental pneumococcal acute otitis media treated with amoxicillin or erythromycin.
|
Pediatr Res
|
2006
|
0.75
|
|
31
|
Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
|
Clin Ther
|
2005
|
0.75
|
|
32
|
Is it possible to achieve bacterial eradication in otitis media with effusion by empirical antibiotic high doses and concomitant administration of acetaminophen? A microbiological and pharmacological study in the gerbil model.
|
Int J Antimicrob Agents
|
2003
|
0.75
|
|
33
|
[Pneumococcal septic arthritis in a Spanish university hospital (1993- 2003)].
|
Enferm Infecc Microbiol Clin
|
2005
|
0.75
|
|
34
|
[Infections of the urinary tract caused by permanent catheterization. Natural history, infective mechanisms and prevention strategies. An overall review based on our clinical experience and research].
|
Arch Esp Urol
|
2007
|
0.75
|
|
35
|
Urine bactericidal activity after administration of gemifloxacin and trovafloxacin single doses in a phase I study.
|
Int J Antimicrob Agents
|
2002
|
0.75
|
|
36
|
Optimal co-amoxiclav ratios for inhibiting Escherichia coli strains with different susceptibilities to the compounds.
|
Int J Antimicrob Agents
|
2005
|
0.75
|
|
37
|
Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by beta-lactam-susceptible and highly resistant pneumococci.
|
Int J Antimicrob Agents
|
2010
|
0.75
|